167 related articles for article (PubMed ID: 35522251)
1. Atypical Case of MOG Antibody-Associated Optic Neuritis with Roth Spots.
Aboab J; Errera MH; Espinoza S; Girmens JF; Héron E
Ocul Immunol Inflamm; 2023 Jul; 31(5):1068-1072. PubMed ID: 35522251
[TBL] [Abstract][Full Text] [Related]
2. Optic perineuritis with anti-myelin oligodendrocyte glycoprotein antibody.
Yanagidaira M; Hattori T; Emoto H; Kiyosawa M; Yokota T
Mult Scler Relat Disord; 2020 Feb; 38():101444. PubMed ID: 31711001
[TBL] [Abstract][Full Text] [Related]
3. Myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis: Clinical Characteristics, Radiologic Clues, and Outcome.
Chen JJ; Flanagan EP; Jitprapaikulsan J; López-Chiriboga ASS; Fryer JP; Leavitt JA; Weinshenker BG; McKeon A; Tillema JM; Lennon VA; Tobin WO; Keegan BM; Lucchinetti CF; Kantarci OH; McClelland CM; Lee MS; Bennett JL; Pelak VS; Chen Y; VanStavern G; Adesina OO; Eggenberger ER; Acierno MD; Wingerchuk DM; Brazis PW; Sagen J; Pittock SJ
Am J Ophthalmol; 2018 Nov; 195():8-15. PubMed ID: 30055153
[TBL] [Abstract][Full Text] [Related]
4. VENOUS STASIS RETINOPATHY SECONDARY TO MYELIN OLIGODENDROCYTE GLYCOPROTEIN ANTIBODY-POSITIVE OPTIC NEURITIS.
Lukewich MK; Micieli JA
Retin Cases Brief Rep; 2022 May; 16(3):305-307. PubMed ID: 32015273
[TBL] [Abstract][Full Text] [Related]
5. Clinical phenotype, radiological features, and treatment of myelin oligodendrocyte glycoprotein-immunoglobulin G (MOG-IgG) optic neuritis.
Chen JJ; Bhatti MT
Curr Opin Neurol; 2020 Feb; 33(1):47-54. PubMed ID: 31743235
[TBL] [Abstract][Full Text] [Related]
6. [Clinical characteristics of myelin oligodendrocyte glycoprotein antibody-positive optic neuritis].
Song HL; Wei SH
Zhonghua Yan Ke Za Zhi; 2019 Mar; 55(3):174-179. PubMed ID: 30841683
[No Abstract] [Full Text] [Related]
7. Resolution of myelin oligodendrocyte glycoprotein (MOG)-IgG optic neuritis without treatment.
Vosoughi AR; Micieli JA
Mult Scler Relat Disord; 2020 Nov; 46():102456. PubMed ID: 32853896
[TBL] [Abstract][Full Text] [Related]
8. Orbital Inflammation in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: A Case Report and Review of the Literature.
Liou VD; Yoon MK; Maher M; Chwalisz BK
J Neuroophthalmol; 2022 Mar; 42(1):e56-e62. PubMed ID: 34999653
[TBL] [Abstract][Full Text] [Related]
9. [Optic neuropathy in positive anti-MOG antibody syndrome].
Merabtene L; Vignal Clermont C; Deschamps R
J Fr Ophtalmol; 2019 Dec; 42(10):1100-1110. PubMed ID: 31732265
[TBL] [Abstract][Full Text] [Related]
10. Clinical profile, imaging features and short term visual outcomes of Indian optic neuritis patients with and without seromarkers for myelin oligodendrocyte glycoprotein and neuromyelitis optica.
Ambika S; Durgapriyadarshini S; Padmalakshmi K; Noronha V; Arjundas D
Indian J Ophthalmol; 2022 Jan; 70(1):194-200. PubMed ID: 34937238
[TBL] [Abstract][Full Text] [Related]
11. Paediatric MOG-antibody disease presenting with intracranial hypertension and unilateral vision loss without radiological evidence of optic neuritis.
Maran JJ; Sharpe C; Carroll S
J Neuroimmunol; 2023 May; 378():578083. PubMed ID: 37058851
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of Myelin Oligodendrocyte Glycoprotein and Aquaporin-4-IgG in Patients in the Optic Neuritis Treatment Trial.
Chen JJ; Tobin WO; Majed M; Jitprapaikulsan J; Fryer JP; Leavitt JA; Flanagan EP; McKeon A; Pittock SJ
JAMA Ophthalmol; 2018 Apr; 136(4):419-422. PubMed ID: 29470571
[TBL] [Abstract][Full Text] [Related]
13. Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis in a post-COVID-19 infection patient.
Zaini MA; Mohd Zain A; Md Din N; Lam C
Immun Inflamm Dis; 2023 Oct; 11(10):e1051. PubMed ID: 37904693
[TBL] [Abstract][Full Text] [Related]
14. A case of MOG antibody-positive bilateral optic neuritis and meningoganglionitis following a genital herpes simplex virus infection.
Nakamura M; Iwasaki Y; Takahashi T; Kaneko K; Nakashima I; Kunieda T; Kaneko S; Kusaka H
Mult Scler Relat Disord; 2017 Oct; 17():148-150. PubMed ID: 29055448
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and prognosis of myelin oligodendrocyte glycoprotein antibody-seropositive paediatric optic neuritis in China.
Song H; Zhou H; Yang M; Tan S; Wang J; Xu Q; Liu H; Wei S
Br J Ophthalmol; 2019 Jun; 103(6):831-836. PubMed ID: 30049802
[TBL] [Abstract][Full Text] [Related]
16. Myelin oligodendrocyte glycoprotein antibody-associated diffuse orbital inflammation.
Deschamps R; Poillon G; Marill A; Marignier R; Gout O; Sene T
Mult Scler; 2020 Oct; 26(11):1441-1443. PubMed ID: 32539531
[TBL] [Abstract][Full Text] [Related]
17. Myelin Oligodendrocyte Glycoprotein-IgG-positive Recurrent Bilateral Optic Papillitis with Serous Retinal Detachment.
Kon T; Hikichi H; Ueno T; Suzuki C; Nunomura J; Kaneko K; Takahashi T; Nakashima I; Tomiyama M
Intern Med; 2018 Nov; 57(22):3307-3312. PubMed ID: 29780155
[TBL] [Abstract][Full Text] [Related]
18. Unique characteristics of optical coherence tomography (OCT) results and visual acuity testing in myelin oligodendrocyte glycoprotein (MOG) antibody positive pediatric patients.
Narayan RN; McCreary M; Conger D; Wang C; Greenberg BM
Mult Scler Relat Disord; 2019 Feb; 28():86-90. PubMed ID: 30576847
[TBL] [Abstract][Full Text] [Related]
19. Current understanding of the epidemiologic and clinical characteristics of optic neuritis.
Nakazawa M; Ishikawa H; Sakamoto T
Jpn J Ophthalmol; 2021 Jul; 65(4):439-447. PubMed ID: 34021411
[TBL] [Abstract][Full Text] [Related]
20. Five-year visual outcomes after optic neuritis in anti-MOG antibody-associated disease.
Akaishi T; Himori N; Takeshita T; Misu T; Takahashi T; Takai Y; Nishiyama S; Fujimori J; Ishii T; Aoki M; Fujihara K; Nakazawa T; Nakashima I
Mult Scler Relat Disord; 2021 Nov; 56():103222. PubMed ID: 34461572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
